Global Coronary Artery Bypass Graft Surgery Market Size By Type (Bare Metal Stent, Drug Eluting Stent), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Coronary Artery Bypass Graft (CABG) Surgery Market was valued at USD 15.7 billion in 2023 and is expected to reach USD 25.4 billion by 2031, growing at a CAGR of 6.3% during the forecast period of 2023 to 2031. This market is driven by the rising prevalence of coronary artery disease (CAD), an aging population, and increasing adoption of minimally invasive surgical techniques. As the global burden of cardiovascular diseases grows, CABG remains a critical surgical intervention for restoring normal blood flow to the heart, especially in cases where angioplasty is not effective.

Drivers:

1. Rising Incidence of Cardiovascular Diseases:

The global rise in sedentary lifestyles, unhealthy diets, and stress levels has led to a surge in coronary artery disease cases, fueling the demand for coronary artery bypass graft surgeries.

2. Advancements in Surgical Techniques and Devices:

Technological innovations, including the development of minimally invasive and robot-assisted CABG procedures, are enhancing surgical outcomes, reducing hospital stays, and improving patient recovery times.

3. Aging Population:

A growing elderly population, particularly in developed regions, is highly susceptible to heart conditions, thereby contributing to an increased volume of CABG procedures.

Restraints:

1. High Cost of Surgery and Post-Operative Care:

The cost-intensive nature of CABG surgery, including hospital charges and recovery costs, often limits accessibility, especially in low-income and developing countries.

2. Availability of Alternative Treatments:

Non-invasive treatment options like angioplasty with stenting and medical therapy are being preferred in some cases, potentially reducing the patient pool eligible for CABG.

Opportunity:

1. Market Growth in Emerging Economies:

Countries in Asia-Pacific and Latin America are witnessing rapid growth in healthcare infrastructure and access to surgical care, offering untapped potential for CABG procedures.

2. Integration of AI and Robotics in Surgery:

The integration of robotic-assisted surgical systems and AI-driven diagnostics is expected to enhance precision and efficiency, opening new frontiers in CABG treatment.

Market by System Type Insights:

Based on system type, the On-pump CABG segment accounted for the largest market share in 2023. On-pump surgery, which uses a heart-lung machine, is widely used due to its familiarity among surgeons and better visibility during procedures. However, the Off-pump CABG segment is expected to grow significantly due to reduced complication rates and faster recovery, especially for high-risk patients.

Market by End-use Insights:

In terms of end-use, Hospitals dominated the market in 2023, accounting for over 60% of the revenue share. This dominance is due to the availability of advanced infrastructure and skilled cardiothoracic surgeons. The Cardiac Specialty Clinics segment is expected to witness strong growth due to increased preference for specialized cardiac care and the trend towards outpatient procedures.

Market by Regional Insights:

North America led the global coronary artery bypass graft surgery market in 2023, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and widespread adoption of robotic surgeries. The Asia-Pacific region is projected to be the fastest-growing market during the forecast period, fueled by rising healthcare investments, increasing awareness, and a growing patient population.

Competitive Scenario:

Key players in the market include Medtronic plc, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, Johnson & Johnson, Getinge AB, Edwards Lifesciences Corporation, Abbott Laboratories, and Maquet Holding B.V. & Co. KG. Companies are focusing on strategic collaborations, R&D investment, and innovation in surgical equipment and graft materials. For instance:

In 2024, Medtronic launched a new robotic-assisted CABG platform aimed at improving surgical precision.

In 2023, LivaNova introduced a next-gen biocompatible vascular graft designed to reduce post-surgical complications.

Scope of Work – Global Coronary Artery Bypass Graft Surgery Market

Report Metric Details

Market Size (2023) USD 15.7 Billion

Projected Market Size (2031) USD 25.4 Billion

CAGR (2023–2031) 6.3%

Market Segments By System Type (On-pump, Off-pump), By End-Use

Growth Drivers Rising CAD incidence, aging population, surgical advancements

Opportunities Robotic surgery integration, emerging market expansion

Key Market Developments:

2024: Terumo Corporation unveiled a compact heart-lung machine optimized for minimally invasive bypass surgeries.

2023: Boston Scientific acquired a start-up specializing in biodegradable graft materials to enhance its CABG portfolio.

2023: Getinge AB expanded its cardiac surgery suite offerings with AI-powered monitoring systems for improved surgical outcomes.

FAQs:

1) What is the current market size of the Global Coronary Artery Bypass Graft Surgery Market?

The market was valued at USD 15.7 billion in 2023.

2) What is the major growth driver of the Global Coronary Artery Bypass Graft Surgery Market?

The rising incidence of coronary artery